President Donald Trump looks on after a man fainted during an announcement about weight-loss drugs in the Oval Office of the White House on Nov. 6, 2025. Andrew Caballero-Reynolds/AFP via Getty ImagesA man fainted in the Oval Office on Nov. 6 as the Trump administration announced sweeping price cuts to popular GLP-1 weight loss drugs, such as Ozempic and Wegovy, starting in early 2026.Eli Lilly CEO David A. Ricks was speaking about the deal when an unidentified man behind him, wearing a black suit, white shirt, and gray tie, started to sway back and forth.
Man Faints in Oval Office as Trump Admin Announces Price Cuts in Weight-Loss Drugs
Related Articles
BusinessCompaniesEnergy
EQT to Buy Range Resources, Creating Largest US Natural Gas Producer
EQT Corp. has agreed to acquire rival Appalachian shale driller Range Resources...
BrightBusinessInvestingPersonal FinanceStocks
Wall Street Is Very NervousShould You Worry? Can You Repair Your Losses?
On Oct. 23, the Dow Jones Industrial Average fell 652.82 points, or...
BusinessMarkets
Nearly 3 in 10 New-Car Trade-Ins Are Underwater, Edmunds Finds
Almost three in 10 vehicles traded toward a new car are worth...
Asia & PacificChina NewsEuropeInternational RelationsNational SecurityPolicies & ImpactsUSUS NewsUS-China RelationsWorld News
Japan Defense Academy Chief Calls for 3 Red Lines in Competition With China
Japan’s former top uniformed military officer has called for establishing three “red...
